Skip to main content
June 13, 2012
Source - Xconomy.com
Doug Hawkins, the associate division chief for hematology/oncology at Seattle Children’s Hospital, says genome sequencing in its current form “is an incredibly powerful tool” for generating new data about the biology of health and disease, but careful studies will need to be done before it can provide a reliable guide for physician decision making.
I loved “The Fault in Our Stars.” Both the book and the movie. I read the book a few years ago during a flight. I cried so hard ... cont.
Dr. James Olson is a pediatric oncologist at Seattle Children’s, and the scientist who developed a compound using a protein ... cont.
In less than two weeks, Jack Conover went from being a 7-year-old in need of a heart transplant to a vibrant boy walking out of ... cont.
Seattle Children’s provides healthcare without regard to race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry) or disability. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.
© 1995-2014 Seattle Children’s Hospital